Virpax Pharmaceuticals

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it recently filed a new provisional patent application with the United States Patent and Trademark Office (‘USPTO’) entitled “NSAID Formulation …

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method Read More


Marinus Pharmaceuticals

Marinus Pharmaceuticals Announces New Method of Use Patent Granted for IV Ganaxolone by USPTO in Status Epilepticus

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) announced that the United States Patent and Trademark Office (USPTO) recently granted a new method of use patent for intravenous (IV) ganaxolone …

Marinus Pharmaceuticals Announces New Method of Use Patent Granted for IV Ganaxolone by USPTO in Status Epilepticus Read More